Liquidia Corp. (LQDA)
57.43
-0.69
(-1.19%)
USD |
NASDAQ |
Nov 13, 16:00
56.70
-0.73
(-1.27%)
After-Hours: 19:59
Liquidia Net Income (Quarterly) : -236.33M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -236.33M |
| June 30, 2026 | 74.72M |
| March 31, 2026 | 52.86M |
| December 31, 2025 | 14.56M |
| September 30, 2025 | -3.533M |
| June 30, 2025 | -41.58M |
| March 31, 2025 | -38.37M |
| December 31, 2024 | -38.51M |
| September 30, 2024 | -31.03M |
| June 30, 2024 | -28.67M |
| March 31, 2024 | -30.08M |
| December 31, 2023 | -27.45M |
| September 30, 2023 | -15.79M |
| June 30, 2023 | -23.52M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -6.533M |
| September 30, 2022 | -9.092M |
| June 30, 2022 | -9.447M |
| March 31, 2022 | -15.94M |
| December 31, 2021 | -11.56M |
| Date | Value |
|---|---|
| September 30, 2021 | -7.281M |
| June 30, 2021 | -6.552M |
| March 31, 2021 | -9.183M |
| December 31, 2020 | -16.09M |
| September 30, 2020 | -14.97M |
| June 30, 2020 | -13.92M |
| March 31, 2020 | -14.79M |
| December 31, 2019 | -14.49M |
| September 30, 2019 | -13.42M |
| June 30, 2019 | -5.901M |
| March 31, 2019 | -13.77M |
| December 31, 2018 | -9.686M |
| September 30, 2018 | -9.673M |
| June 30, 2018 | -6.269M |
| March 31, 2018 | -27.51M |
| December 31, 2017 | 8.210M |
| September 30, 2017 | -19.24M |
| June 30, 2017 | -8.291M |
| March 31, 2017 | -9.837M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| United Therapeutics Corp. | 258.60M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 6.451B |
| Pfizer Inc. | 3.251B |
| Amneal Pharmaceuticals, Inc. | 12.31M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 461.63M |
| EPS Diluted (Quarterly) | -2.640 |
| Enterprise Value | 4.988B |
| Gross Profit Margin (Quarterly) | 93.33% |
| Profit Margin (Quarterly) | -104.9% |
| Earnings Yield | -2.15% |
| Operating Earnings Yield | 5.21% |
| Normalized Earnings Yield | 3.157 |